Imaging of drug-induced complications in the gastrointestinal system

Radiographics

Volumn 36, Issue 1, 2016, Pages 71-87

  McGettigan, Melissa J ^a   Menias, Christine O ^b   Gao, Zhenqiang J ^a   Mellnick, Vincent M ^c   Hara, Amy K ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MICROCAPSULE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE EFFECTS; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL DISEASES; HUMAN; MICROCAPSULE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CAPSULES; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84955474552     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.2016150132     Document Type: Article

References (76)

1. Gordon IO, Konda V, Noffsinger AE. Drug-induced injury of the gastrointestinal tract. Surg Pathol Clin 2010;3(2): 361–393.
2. Tutuian R; Clinical Lead Outpatient Services and Gastrointestinal Function Laboratory. Adverse effects of drugs on the esophagus. Best Pract Res Clin Gastroenterol 2010;24(2):91–97.
3. Levine MS, Rubesin SE. Diseases of the esophagus: diagnosis with esophagography. Radiology 2005;237(2):414–427.
4. Gómez V, Xiao SY. Alendronate-induced esophagitis in an elderly woman. Int J Clin Exp Pathol 2009;2(2):200–203.
5. Bailey RT Jr, Bonavina L, McChesney L, et al. Factors influencing the transit of a gelatin capsule in the esophagus. Drug Intell Clin Pharm 1987;21(3):282–285.
6. Vãlean S, Petrescu M, Cãtinean A, Chira R, Mircea PA. Pill esophagitis. Rom J Gastroenterol 2005;14(2):159–163.
7. Eisenberg RL. Gastrointestinal radiology: a pattern approach. 4th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins, 2003; 55–67, 102–108, 896–897.
8. DeGaeta L, Levine MS, Guglielmi GE, Raffensperger EC, Laufer I. Herpes esophagitis in an otherwise healthy patient. AJR Am J Roentgenol 1985;144(6):1205–1206.
9. Lee SS, Ha HK, Byun JH, et al. Superficial esophageal cancer: esophagographic findings correlated with histopathologic findings. Radiology 2005;236(2):535–544.
10. Vella V. Drug-induced peptic ulcer disease. J Malta Coll Pharm Pract 2005;10:15–19.
11. Matsui H, Shimokawa O, Kaneko T, Nagano Y, Rai K, Hyodo I. The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)–induced mucosal injuries in stomach and small intestine. J Clin Biochem Nutr 2011;48 (2):107–111.
12. Peskar BM. Role of cyclooxygenase isoforms in gastric mucosal defence. J Physiol Paris 2001;95(1–6):3–9.
13. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998;104(5):413–421.
14. Perini RF, Ma L, Wallace JL. Mucosal repair and COX-2 inhibition. Curr Pharm Des 2003;9(27):2207–2211.
15. Patterson MK, Castellsague J, Walker AM. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib. Pharmacoepidemiol Drug Saf 2008;17(10):982–988.
16. Ma L, del Soldato P, Wallace JL. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: shifting the angiogenic balance. Proc Natl Acad Sci U S A 2002;99(20):13243–13247.
17. Howes LG. Selective COX-2 inhibitors, NSAIDs and cardiovascular events: is celecoxib the safest choice? Ther Clin Risk Manag 2007;3(5):831–845.
18. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself? Physiol Rev 2008;88(4):1547–1565.
19. Rubesin SE, Levine MS, Laufer I. Double-contrast upper gastrointestinal radiography: a pattern approach for diseases of the stomach. Radiology 2008;246(1):33–48.
20. Freeman AH, Sala E. Conventional radiology of the stomach and duodenum. In: Freeman AH, Sala E, eds. Radiology of the stomach and duodenum. New York, NY: Springer, 2008; 40–43.
21. Gore RM, Levine MS. Textbook of gastrointestinal radiology. 4th ed. Philadelphia, Pa: Elsevier Saunders, 2015; 467–477, 1639, 1680–1696.
22. Tsianos E, Gossios K. CT evaluation of benign gastric lesions. Ann Gastroenterol 2004;17(1):31–36.
23. Carter J, Durfee J. A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Gynecol Oncol 2007;107(3):586–589.
24. Sliesoraitis S, Tawfik B. Bevacizumab-induced bowel perforation. J Am Osteopath Assoc 2011;111(7):437–441.
25. Bateman N, Kerr S. Gastrointestinal disorders. In: Lee A, ed. Adverse drug reactions. 2nd ed. London, England: Pharmaceutical Press, 2006; 157–183.
26. Boelsterli UA, Redinbo MR, Saitta KS. Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol Sci 2013; 131(2):654–667.
27. Kelly ME, McMahon LE, Jaroszewski DE, Yousfi MM, De Petris G, Swain JM. Small-bowel diaphragm disease: seven surgical cases. Arch Surg 2005;140(12):1162–1166.
28. Hatti K, Giuliano V. NSAID induced small bowel strictures. Ann Orthop Rheumatol 2014;2(1):1011.
29. Flicek KT, Hara AK, De Petris G, Pasha SF, Yadav AD, Johnson CD. Diaphragm disease of the small bowel: a retrospective review of CT findings. AJR Am J Roentgenol 2014;202(2):W140–W145.
30. Radwin MI. NSAID enteropathy and capsule retention; complication or guide to therapy? Visible Human Journal of Endoscopy 2009;8(2). http://www.vhjoe.org/Volume8Is sue2/8-2-4.htm. Published 2009. Accessed February 15, 2015.
31. Manchalapati P, Cave DR. Capsule retention: it’s not all bad! Visible Human Journal of Endoscopy 2010;9(2). http:// www.vhjoe.org/index.php/vhjoe/article/view/20/19. Published 2010. Accessed February 15, 2015.
32. Hara AK, Leighton JA, Sharma VK, Heigh RI, Fleischer DE. Imaging of small bowel disease: comparison of capsule endoscopy, standard endoscopy, barium examination, and CT. RadioGraphics 2005;25(3):697–711; discussion 711–718.
33. Matsumoto T, Iida M, Nakamura S, Hizawa K, Yao T, Fujishima M. Crohn’s disease of aphthous type: serial changes in intestinal lesions. Br J Radiol 2000;73(874):1046–1051.
34. Dilauro S, Crum-Cianflone NF. Ileitis: when it is not Crohn’s disease. Curr Gastroenterol Rep 2010;12(4): 249–258.
35. Chung SH, Jo Y, Ryu SR, et al. Diaphragm disease compared with cryptogenic multifocal ulcerous stenosing enteritis. World J Gastroenterol 2011;17(23):2873–2876.
36. De Backer AI, De Schepper AM, Vandevenne JE, Schoeters P, Michielsen P, Stevens WJ. CT of angioedema of the small bowel. AJR Am J Roentgenol 2001;176(3):649–652.
37. Scheirey CD, Scholz FJ, Shortsleeve MJ, Katz DS. Angiotensin-converting enzyme inhibitor–induced small-bowel angioedema: clinical and imaging findings in 20 patients. AJR Am J Roentgenol 2011;197(2):393–398.
38. Campbell T, Peckler B, Hackstadt RD, Payor A. ACE inhibitor–induced angioedema of the bowel. Case Rep Med 2010;2010:690695.
39. Locascio EJ, Mahler SA, Arnold TC. Intestinal angioedema misdiagnosed as recurrent episodes of gastroenteritis. West J Emerg Med 2010;11(4):391–394.
40. Pear BL. Pneumatosis intestinalis: a review. Radiology 1998;207(1):13–19.
41. Ho LM, Paulson EK, Thompson WM. Pneumatosis intestinalis in the adult: benign to life-threatening causes. AJR Am J Roentgenol 2007;188(6):1604–1613.
42. Adar T, Paz K. Images in clinical medicine: pneumatosis intestinalis. N Engl J Med 2013;368(15):e19. http://www .nejm.org/doi/full/10.1056/NEJMicm1205591. Published April 11, 2013. Accessed March 14, 2015.
43. Wu SS, Yen HH. Images in clinical medicine: pneumatosis cystoides intestinalis. N Engl J Med 2011;365(8):e16. http:// www.ncbi.nlm.nih.gov/pubmed/21864163. Published August 25, 2011. Accessed March 14, 2015.
44. Zhang H, Jun SL, Brennan TV. Pneumatosis intestinalis: not always a surgical indication. Case Rep Surg 2012;2012:719713. doi:0.1155/2012/719713. Published November 12, 2012. Accessed March 10, 2015.
45. Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol 2004;99(6):1175–1190.
46. Huber T, Ruchti C, Halter F. Nonsteroidal antiinflammatory drug–induced colonic strictures: a case report. Gastroenterology 1991;100(4):1119–1122.
47. Kawamoto S, Horton KM, Fishman EK. Pseudomembranous colitis: spectrum of imaging findings with clinical and pathologic correlation. RadioGraphics 1999;19(4):887–897.
48. Kirkpatrick ID, Greenberg HM. Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy? AJR Am J Roentgenol 2001;176(3):635–639.
49. Thoeni RF, Cello JP. CT imaging of colitis. Radiology 2006;240(3):623–638.
50. Ramachandran I, Sinha R, Rodgers P. Pseudomembranous colitis revisited: spectrum of imaging findings. Clin Radiol 2006;61(7):535–544.
51. Trudel JL. Clostridium difficile colitis. Clin Colon Rectal Surg 2007;20(1):13–17.
52. Pandit A, Sachdeva T, Bafna P. Drug-induced hepatotoxicity: a review. J Appl Pharm Sci 2012;2(5):233–243.
53. Kshirsagar A, Vetal Y, Ashok P, et al. Drug induced hepatotoxicity: a comprehensive review. The Internet Journal of Pharmacology 2008;7(1). http://ispub.com/IJPHARM/7/1/3723. Published 2008. Accessed February 10, 2015.
54. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000;4(1):73–96, vi.
55. Dağ MS, Aydınlı M, Oztürk ZA, et al. Drug- and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol 2014;25(1):41–45.
56. Drug-induced Liver Injury Network. National Institute of Diabetes and Digestive and Kidney Diseases Web site. https://dilin.dcri.duke.edu/. Updated April 17, 2013. Accessed February 4, 2015.
57. LiverTox: clinical and research information on drug-induced liver injury. National Institutes of Health. http://www.livertox.nih.gov/. Updated January 29, 2015. Accessed March 18, 2015.
58. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB. Fatty liver: imaging patterns and pitfalls. RadioGraphics 2006;26(6):1637–1653.
59. Holt MP, Ju C. Mechanisms of drug-induced liver injury. AAPS J 2006;8(1):e48–e54. doi:10.1208/aapsj080106. Published February 3, 2006. Accessed February 10, 2015.
60. Miyayama S, Yamashiro M, Okuda M, et al. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2010;33(6):1168–1179.
61. Faria LC, Resende CC, Couto CA, Couto OF, Fonseca LP, Ferrari TC. Severe and prolonged cholestasis caused by trimethoprim-sulfamethoxazole: a case report. Clinics (Sao Paulo) 2009;64(1):71–74.
62. Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology 2011;53(4):1377–1387.
63. Bhamidimarri KR, Schiff E. Drug-induced cholestasis. Clin Liver Dis 2013;17(4):519–531, vii.
64. ElSayed EY, El Maati AA, Mahfouz M. Diagnostic value of magnetic resonance cholangiopancreatography in cholestatic jaundice. Egypt J Radiol Nucl Med 2013;44(2):137–146.
65. Gossard AA. Diagnosis of cholestasis. In: Carey EJ, Lindor KD, eds. Cholestatic liver disease. 2nd ed. New York, NY: Springer, 2014; 1–12.
66. Dignan FL, Wynn RF, Hadzic N, et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 2013;163(4):444–457.
67. Zhou H, Wang Y-XJ, Lou HY, Xu XJ, Zhang MM. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol 2014;15(2):218–225.
68. Brancatelli G, Vilgrain V, Federle MP, et al. Budd-Chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol 2007;188(2):W168–W176.
69. Ramachandran R, Kakar S. Histological patterns in drug-induced liver disease. J Clin Pathol 2009;62(6):481–492.
70. Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med 2014;138(8):1090–1097.
71. Nault JC, Zucman Rossi J. Molecular classification of hepatocellular adenomas. Int J Hepatol 2013;2013:315947.
72. Grazioli L, Olivetti L, Mazza G, Bondioni MP. MR imaging of hepatocellular adenomas and differential diagnosis dilemma. Int J Hepatol 2013;2013:374170.
73. Agarwal S, Fuentes-Orrego JM, Arnason T, et al. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol 2014;203(4):W408–W414.
74. Kaurich T. Drug-induced acute pancreatitis. Proc Bayl Univ Med Cent 2008;21(1):77–81.
75. Tenner S. Drug induced acute pancreatitis: does it exist? World J Gastroenterol 2014;20(44):16529–16534.
76. Torrisi JM, Schwartz LH, Gollub MJ, Ginsberg MS, Bosl GJ, Hricak H. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 2011;258(1):41–56.